Skip to main content
. 2019 Nov-Dec;35(6):1647–1651. doi: 10.12669/pjms.35.6.1287

Table II.

Comparison between Two Groups after Treatment.

Variable Study population n=52 Group A (FTO Group) n=25 Group B (PTO Group) n=27
Pre-treatment BCVA (Snellen’s value) (%)
6/60 5 (9.6) 3 (12) 2 (7.4)
6/48 11 (21.2) 6 (24) 5(18.5)
6/36 9 (17.3) 1 (4) 8(29.6)
6/24 21 (40.4) 13 (52) 8(29.6)
6/12 6 (11.5) 2 (8) 4(14.8)
6/7.5 - - -
6/6 - - -
Post-treatment BCVA (Snellen’s value) (%)
6/60 - - -
6/48 - - -
6/36 - - -
6/24 11 (21.2) 2 (8) 9(33.3)
6/12 23 (44.2) 12 (48) 11(40.7)
6/7.5 17 (32.7) 10 (40) 7(25.9)
6/6 1 (1.9) 1 (4) -